Summary: American Life Sciences Competitiveness Act of 2007 - Amends the Internal Revenue Code to allow biomedical research corporations to: (1) engage in investment activity involving shifts in ownership without incurring limitations on net operating loss carryforwards; (2) claim a full research and development tax credit for contract research expenses (currently, limited to 65%); (3) claim a business tax credit for 20% of eligible countermeasures research expenses (for biomedical threats); and (4) claim a tax-free rollover of gain from stock sales reinvested in another biomedical research corporation.Expands the tax credit for clinical testing expenses for drugs to treat rare diseases (orphan drugs) to include expenses incurred after an application is made to the Food and Drug Administration (FDA) but before receipt of an orphan drug designation.Allows individual taxpayers a 20% tax credit for equity investments in small biomedical research firms engaged in incubational research (i.e., research conducted prior to large-scale clinical trials).

american life sciences competitiveness act amends_the_internal_revenue_code allow biomedical research corporations engage investment activity involving shifts ownership incurring limitations net operating loss claim research development tax credit contract research expenses currently limited claim business tax credit eligible countermeasures research expenses biomedical threats claim tax free rollover gain stock sales reinvested biomedical research corporation expands tax credit clinical testing expenses drugs treat rare diseases orphan drugs include expenses incurred application food_and_drug_administration fda receipt orphan drug designation allows individual taxpayers tax credit equity investments small biomedical research firms engaged research research conducted prior large scale clinical trials


Summary: SMA Treatment Acceleration Act - Requires the Director of the National Institutes of Health (NIH) to upgrade and unify existing spinal muscular atrophy (SMA) clinical trial sites to establish a national clinical trials network for SMA. Requires the Director of NIH to ensure that such network: (1) conducts coordinated, multisite, clinical trials of pharmacological approaches to the treatment of SMA; and (2) rapidly and effectively disseminates scientific findings to the field.Requires the Director of NIH to: (1) establish an SMA data coordinating center; and (2) expand and intensify NIH programs with respect to preclinical translation research and medicinal chemistry related to SMA.Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enhance and provide ongoing support to the existing SMA patient registry to provide for expanded research on the epidemiology of SMA. Directs the Secretary to ensure the collection and analysis of longitudinal data related to individuals of all ages with SMA.Requires the Secretary to establish the Spinal Muscular Atrophy Coordinating Committee to: (1) coordinate activities across NIH and with other federal health programs and activities relating to SMA; and (2) conduct a study to identify barriers to the development of drugs for treating SMA and similar genetic disorders.Requires the Director of NIH to establish a trans-National Institutes of Health cooperative research initiative on SMA to ensure the success of the SMA projects led by the National Institute of Neurological Disorders and Stroke. Requires the Secretary to submit recommendations to Congress to improve and expand on incentives provided under the Orphan Drug Act and related statutes to promote SMA drug development.

treatment acceleration act_-_requires director national_institutes_of_health nih upgrade existing spinal clinical trial sites establish national clinical trials network requires director nih ensure network conducts coordinated multisite clinical trials pharmacological approaches treatment rapidly effectively disseminates scientific findings field requires director nih establish data coordinating center expand intensify nih programs respect preclinical translation research chemistry related secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc enhance provide ongoing support existing patient registry provide expanded research epidemiology directs secretary ensure collection analysis longitudinal data related individuals ages secretary establish spinal coordinating committee coordinate activities nih federal health programs activities relating conduct study identify barriers development drugs treating similar genetic disorders requires director nih establish trans national_institutes_of_health cooperative research initiative ensure success projects led national institute neurological disorders stroke requires secretary submit recommendations congress improve expand incentives provided orphan drug act related statutes promote drug development


Summary: Pulmonary Hypertension Research and Education Act of 2007 - Amends the Public Health Service Act to require the Director of the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate the Institute's pulmonary hypertension research activities. Requires the Director to establish a Pulmonary Hypertension Clinical Research Network to conduct clinical trials to evaluate new treatment approaches for pulmonary hypertension and facilitate collaboration among investigators with expertise in pulmonary hypertension. Directs the network to include: (1) a steering committee; and (2) an Institute project scientist. Provides for the establishment of a national Pulmonary Hypertension Preceptorship and Training Program to facilitate the direct education and training of medical professionals by experienced pulmonary hypertension specialists in clinical settings. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to develop and disseminate to the public information regarding pulmonary hypertension. Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to develop and disseminate to health care providers information on pulmonary hypertension to ensure that providers remain informed about the disease, its presenting symptoms, and current treatment options. Requires the Comptroller General to conduct a study on the coverage standards that apply to individuals with pulmonary hypertension under Medicare and Medicaid.

pulmonary hypertension research education act amends public_health_service_act require director national_heart lung blood_institute expand intensify coordinate institute pulmonary hypertension research activities requires director establish pulmonary hypertension clinical research network conduct clinical trials evaluate new treatment approaches pulmonary hypertension facilitate collaboration investigators expertise pulmonary hypertension directs network include steering committee institute project scientist provides establishment national pulmonary hypertension training program facilitate direct education training medical professionals experienced pulmonary hypertension specialists clinical settings requires secretary acting director centers_for_disease_control_and_prevention cdc develop disseminate public information pulmonary hypertension requires secretary acting administrator health_resources_and_services_administration hrsa director cdc develop disseminate health_care providers information pulmonary hypertension ensure providers remain informed disease presenting symptoms current treatment options requires comptroller_general conduct study coverage standards apply individuals pulmonary hypertension medicare medicaid


Summary: Methamphetamine Treatment and Rehabilitation Best Practices Act of 2007 - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to conduct a survey of research available on methamphetamine addiction and treatment, with a focus on reviewing research on the best treatment for methamphetamine addiction, rehabilitation, and recovery. Requires the Secretary to report to Congress on the findings of the survey and include recommendations for additional research avenues focusing on methamphetamine addiction and treatment.

methamphetamine treatment rehabilitation best practices act requires secretary health_and_human_services acting director national_institutes_of_health nih conduct survey research available methamphetamine addiction treatment focus reviewing research best treatment methamphetamine addiction rehabilitation recovery requires secretary report congress findings survey include recommendations additional research avenues focusing methamphetamine addiction treatment


Summary: Paget's Cancer Awareness Act - Directs the Secretary of Health and Human Services to carry out a program to provide information and education to health professionals and the public on the symptoms of and treatment for Paget's disease of the breast. Requires the Secretary to study aspects of the disease concerning the range of symptoms, time lapse between the onset of symptoms and diagnosis and treatment, and demographic distribution.

cancer awareness act_-_directs secretary health_and_human_services carry program provide information education health professionals public symptoms treatment disease breast requires secretary study aspects disease concerning range symptoms time lapse onset symptoms diagnosis treatment demographic distribution


Summary: Taxpayers' Cancer Research Funding Act of 2007- Amends the Internal Revenue Code to allow taxpayers to designate on their tax returns a $5 contribution to the Breast and Prostate Cancer Research Fund ($10 for joint returns). Establishes in the Treasury the Breast and Prostate Cancer Research Fund to award grants for breast or prostate cancer research.

taxpayers cancer research funding act amends_the_internal_revenue_code allow taxpayers designate tax returns contribution breast prostate cancer research fund joint returns establishes treasury breast prostate cancer research fund award grants breast prostate cancer research


Summary: Prostate Research, Imaging, and Men's Education Act of 2007 or the PRIME Act of 2007 - Requires the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to: (1) carry out a program to expand and intensify research to develop advanced imaging technologies for prostate cancer detection, diagnosis, and treatment comparable to mammogram technology; and (2) utilize the National Institute of Biomedical Imaging and Bioengineering and the National Cancer Institute for advanced stages of research in prostate imaging. Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration, to: (1) carry out a grant program to encourage the early stages of research in prostate imaging to develop and implement new ideas, proof of concepts, and pilot studies for high-risk technologic innovation; and (2) establish interdisciplinary private-public partnerships to develop research strategies for expedited innovation in imaging and image-guided treatment. Directs the Secretary: (1) to carry out a national campaign to increase awareness and knowledge with respect to the need for prostate cancer screening and for improved detection technologies; (2) in carrying out the program and the campaign, to recognize and address the racial disparities in the incidences of prostate cancer and mortality rates and any racial barriers in access to care and participation in clinical trials; (3) establish a program to award grants to nonprofit private entities to test alternative outreach and education strategies; and (4) carry out research to develop an improved prostate cancer screening blood test using in-vitro detection.

prostate_research imaging men education act prime act requires secretary health_and_human_services acting director national_institutes_of_health nih carry program expand intensify research develop advanced imaging technologies prostate cancer detection diagnosis treatment comparable mammogram technology utilize national institute biomedical imaging national_cancer_institute advanced stages research prostate imaging requires secretary acting administrator health_resources_and_services_administration carry grant program encourage early stages research prostate imaging develop implement new ideas proof concepts pilot studies high risk innovation establish interdisciplinary private public partnerships develop research strategies expedited innovation imaging image guided treatment directs secretary carry national campaign increase awareness knowledge respect need prostate cancer screening improved detection technologies carrying program campaign recognize address racial disparities incidences prostate cancer mortality rates racial barriers access care participation clinical trials establish program award grants nonprofit private entities test alternative outreach education strategies carry research develop improved prostate cancer screening blood test vitro detection


Summary: Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such biomarkers; (3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; and (4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens.Requires the Director to: (1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS); (2) establish an Ovarian Cancer Biomarker Clinical Trial Committee to assist the Director to design and implement national clinical trials to determine the utility of such biomarkers; and (3) establish a national data center to conduct statistical analyses of trial data.

cancer research_act amends public_health_service_act require director national_cancer_institute enter cooperative agreements grants public nonprofit entities establish operate centers conduct research biomarkers use risk early detection screening cancer designates center cancer center_of_excellence allows federal payments agreement grant research development characterization new biomarkers refinement existing biomarkers clinical laboratory validation biomarkers development implementation clinical epidemiological research utilization biomarkers development implementation repositories new tissue biological specimens requires director available research tissue specimens clinical research cancer funded department_of_health_and_human_services hhs establish cancer clinical trial committee assist director design implement national clinical trials determine utility biomarkers establish national data center conduct statistical analyses trial data


Summary: Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to: (1) establish, and appoint the Director of, the Office of Antimicrobial Resistance in the Office of the Assistant Secretary for Health to develop plans for addressing antimicrobial resistance in the United States and internationally; (2) establish the Public Health Antimicrobial Advisory Board to assist the Director; and (3) develop an antimicrobial resistance strategic research plan. Renews the Antimicrobial Resistance Task Force and sets forth its membership and duties.Requires sponsors of human and animal antimicrobial drug products to report to the Office of Antimicrobial Resistance the amount of such drug products sold or distributed in the United States in a calendar year. Requires the Director to make summaries of drug distribution data publicly available.Requires the Secretary to: (1) establish at least 10 Antimicrobial Resistance Clinical Research and Public Health Network sites to describe outbreaks of antimicrobial resistant pathogens and monitor the patterns of such pathogens in individuals; and (2) award competitive grants to establish demonstration projects to assess the scope of the antimicrobial resistance problem and the use of antimicrobial drugs.Requires the Comptroller General to report to Congress on the effectiveness of this Act.

strategies address antimicrobial resistance act_-_amends public_health_service_act direct secretary health_and_human_services establish appoint director office antimicrobial resistance office assistant secretary health develop plans addressing antimicrobial resistance united_states internationally establish public health antimicrobial advisory_board assist director develop antimicrobial resistance strategic research plan renews antimicrobial resistance task_force sets forth membership duties requires sponsors human animal antimicrobial drug products report office antimicrobial resistance drug products sold distributed united_states calendar year requires director summaries drug distribution data publicly available requires secretary establish antimicrobial resistance clinical research public health network sites describe outbreaks antimicrobial resistant pathogens monitor patterns pathogens individuals award competitive grants establish demonstration projects assess scope antimicrobial resistance problem use antimicrobial drugs requires comptroller_general report congress effectiveness act


Summary: Safety of Seniors Act of 2008 - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services to: (1) oversee and support a national education campaign focusing on reducing falls among older adults and preventing repeat falls; and (2) award grants, contracts, or cooperative agreements to design and carry out local education campaigns. Allows the Secretary to conduct and support research to: (1) improve the identification of older adults who have a high risk of falling; (2) improve data collection and analysis to identify fall risk and protective factors; (3) design, implement, and evaluate the most effective fall prevention interventions; (4) tailor effective strategies to reduce falls to specific populations of older adults; (5) maximize the dissemination of proven, effective fall prevention interventions; (6) improve the diagnosis, treatment, and rehabilitation of elderly fall victims and older adults at high risk for falls; and (7) assess the risks of falls occurring in various settings. Authorizes the Secretary to: (1) conduct research concerning the barriers to the adoption of proven fall prevention interventions; (2) conduct research to develop, implement, and evaluate the most effective approaches to reduce falls among high-risk older adults living in communities and long-term care and assisted living facilities; (3) evaluate the effectiveness of community programs; (4) provide professional education for physicians and allied health professionals in fall prevention; (5) oversee and support specified demonstration and research projects; (6) award grants to design, implement, and evaluate fall prevention programs using proven intervention strategies and carry out a multistate demonstration project; (7) give priority in awarding grants under this Act to entities that explore the use of cost-sharing to ensure the institutional commitment of the recipients of such assistance to the funded projects; and (8) report to Congress on the effects of falls on health care costs, the potential for reducing falls, and the most effective strategies for reducing associated health care costs.

safety seniors act amends public_health_service_act authorize secretary health_and_human_services oversee support national education campaign focusing reducing falls older adults preventing repeat falls award grants contracts cooperative agreements design carry local education campaigns allows secretary conduct support research improve identification older adults high risk falling improve data collection analysis identify fall risk protective factors design implement evaluate effective fall prevention interventions tailor effective strategies reduce falls specific populations older adults maximize dissemination proven effective fall prevention interventions improve diagnosis treatment rehabilitation elderly fall victims older adults high risk falls assess risks falls occurring settings authorizes secretary conduct research concerning barriers adoption proven fall prevention interventions conduct research develop implement evaluate effective approaches reduce falls high risk older adults living communities long-term_care assisted living facilities evaluate effectiveness community programs provide professional education physicians allied health professionals fall prevention oversee support specified demonstration research projects award grants design implement evaluate fall prevention programs proven intervention strategies carry multistate demonstration project priority awarding grants act entities explore use cost sharing ensure institutional commitment recipients assistance funded projects report congress effects falls health_care costs potential reducing falls effective strategies reducing associated health_care costs


Summary: Family Asthma Act - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to award grants to eligible entities to conduct pilot projects to prevent and control asthma symptoms and to reduce asthma attacks and improve self-management for individuals and families. Requires the Secretary to give: (1) priority to entities that serve a medically underserved population; and (2) consideration to an adequate rural-urban distribution, so as to gain better information about asthma at the national level. Authorizes additional appropriations to the National Heart, Lung, and Blood Institute to develop a National Asthma Action Plan and to fund a report to Congress by the National Asthma Education and Prevention Program. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collaborate with state and local health departments to conduct activities to inform and educate the public regarding asthma; (2) conduct asthma surveillance activities to collect data on the prevalence and severity of asthma, the effectiveness of public heath asthma intervention, and the quality of asthma management; and (3) compile and annually publish asthma data. Requires the Director of the National Institute of Environmental Health Sciences to establish Dr. Irving J. Selikoff individual and institutional training grants for education and training of health care providers on the role of environmental factors in the development and prevention of asthma and recurrent asthma attacks.

family asthma act_-_amends public_health_service_act authorize secretary health_and_human_services acting director national_institutes_of_health nih award grants eligible entities conduct pilot projects prevent control asthma symptoms reduce asthma attacks improve self management individuals families requires secretary priority entities serve medically underserved population consideration adequate rural urban distribution gain better information asthma national level authorizes additional appropriations national_heart lung blood_institute develop national asthma action plan fund report congress national asthma education prevention program requires secretary acting director centers_for_disease_control_and_prevention cdc collaborate state local health departments conduct activities inform educate public asthma conduct asthma surveillance activities collect data prevalence severity asthma effectiveness public heath asthma intervention quality asthma management compile annually publish asthma data requires director national_institute_of_environmental_health_sciences establish individual institutional training grants education training health_care providers role environmental factors development prevention asthma recurrent asthma attacks


Summary: Amends the Internal Revenue Code to allow a general business tax credit for 50% of expenses paid for research and development of any qualified infectious disease product. Defines "qualified infectious disease product" as any antibiotic drug, antiviral, diagnostic test, biological product, or vaccine developed to treat, detect, prevent, or identify certain pathogens. Terminates such credit after 2012.

amends_the_internal_revenue_code allow general business tax credit expenses paid research development qualified infectious disease product defines qualified infectious disease product antibiotic drug diagnostic test biological product vaccine developed treat detect prevent identify certain pathogens terminates credit


Summary: Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act of 2007 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to expand and intensify CDC's cancer control programs. Requires the Secretary to: (1) provide guidance to states, in collaboration with the Director of the National Cancer Institute (NCI), on interventions that may be incorporated into state cancer control programs to improve the long-term health status of childhood cancer survivors; (2) encourage states to incorporate strategies for improving their care into their comprehensive cancer plans; (3) collaborate with the NCI Director to improve or develop systems for tracking cancer survivors; and (4) enhance control programs to include a focus on childhood cancer survivorship.Directs the NCI Director to: (1) coordinate National Institutes of Health (NIH) activities regarding cancer survivorship; (2) make grants for research regarding pediatric cancer survivors and health disparities in cancer survivorship within minority populations; (3) conduct or support research to evaluate followup care for childhood cancer survivors; and (4) make grants to establish pilot programs to develop, study, or evaluate model systems for monitoring and caring for cancer survivors.Directs the Secretary to make grants to: (1) establish or improve training programs for health care professionals to improve followup care for young cancer survivors and to ensure that such care is linguistically and culturally competent; (2) pay costs incurred during the first four years of operating a clinic for comprehensive long-term followup services for childhood cancer survivors; and (3) improve physical and psychosocial care for such survivors.

pediatric adolescent young adult cancer survivorship research quality life act amends public_health_service_act direct secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc expand intensify cdc cancer control programs requires secretary provide guidance states collaboration director national_cancer_institute interventions incorporated state cancer control programs improve long term health status childhood cancer survivors encourage states incorporate strategies improving care comprehensive cancer plans collaborate director improve develop systems tracking cancer survivors enhance control programs include focus childhood cancer survivorship directs director coordinate national_institutes_of_health nih activities cancer survivorship grants research pediatric cancer survivors health disparities cancer survivorship minority populations conduct support research evaluate care childhood cancer survivors grants establish pilot programs develop study evaluate model systems monitoring caring cancer survivors directs secretary grants establish improve training programs health_care professionals improve care young cancer survivors ensure care linguistically culturally competent pay costs incurred years operating clinic comprehensive long term services childhood cancer survivors improve physical psychosocial care survivors


Summary: MRSA Research and Study Act of 2007 - Amends the Public Health Service Act to direct the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to establish a six-year program under which the Secretary shall award competitive two-year grants to public or private universities or affiliated teaching hospitals to conduct research into preventing, treating, and finding the cure for Methicillin Resistant Staphylococcus Aureus. Requires the Secretary to award at least 25 grants during each two-year period of the program.

research study act amends public_health_service_act direct secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc establish year program secretary shall award competitive year grants public private universities affiliated teaching hospitals conduct research preventing treating finding cure resistant requires secretary award grants year period program


Summary: Robin Danielson Act - Amends the Public Health Service Act to require the Director of the National Institutes of Health (NIH) to provide for the conduct or support of research on the extent to which additives in feminine hygiene products pose any risks to the health of women or the health of the children of women who use those products during or before the pregnancies involved. Directs the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) collect, analyze, and make available data on toxic shock syndrome, including data on the causes of such syndrome; and (2) determine the national incidence and prevalence of such syndrome.

act_-_amends public_health_service_act require director national_institutes_of_health nih provide conduct support research extent additives hygiene products pose risks health women health children women use products pregnancies involved directs secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc collect analyze available data toxic syndrome including data causes syndrome determine national incidence prevalence syndrome


Summary: Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2008 - Amends the Public Health Service Act to designate centers of excellence for research on various forms of muscular dystrophy as Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers.Authorizes the Muscular Dystrophy Interagency Coordinating Committee to evaluate the potential need to enhance the clinical research infrastructure required to test emerging therapies for the various forms of muscular dystrophy.Authorizes the Secretary of Health and Human Services to ensure that any data on patients that is collected as part of the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) is regularly updated to reflect changes in patient condition over time. Requires the Director of the Centers for Disease Control and Prevention (CDC) to report to the appropriate congressional committees on MD STARnet and data collection. Authorizes the Secretary to provide prospective health outcome data on the health and survival of people with muscular dystrophy.Authorizes the Secretary, in carrying out a program to provide information and education on muscular dystrophy to health professionals and the general public, to: (1) partner with leaders in the muscular dystrophy patient community; (2) cooperate with professional organizations and the patient community to develop, issue, and update care considerations for Duchenne-Baker muscular dystrophy and other forms of muscular dystrophy; and (3) widely disseminate such care considerations as broadly as possible, including through partnership opportunities with the muscular dystrophy patient community.

paul community assistance research education_amendments amends public_health_service_act designate centers_of_excellence research forms paul cooperative research centers authorizes interagency_coordinating_committee evaluate potential need enhance clinical research infrastructure required test emerging therapies forms authorizes secretary health_and_human_services ensure data patients collected surveillance tracking research network regularly updated reflect changes patient condition time requires director centers_for_disease_control_and_prevention cdc report appropriate congressional committees data collection authorizes secretary provide prospective health outcome data health survival people authorizes secretary carrying program provide information education health professionals general public partner leaders patient community cooperate professional organizations patient community develop issue update care considerations baker forms widely disseminate care considerations broadly possible including partnership opportunities patient community


Summary: Nino's Act - Amends title XIX (Medicaid) of the Social Security Act to provide for mandatory Medicaid coverage of drugs prescribed for certain research study child participants, regardless of Medicaid eligibility otherwise, if the state provides drug coverage.

act_-_amends title xix medicaid social_security_act provide mandatory medicaid coverage drugs prescribed certain research study child participants regardless medicaid eligibility state provides drug coverage


Summary: Women's Environmental Health and Disease Prevention Act of 2008 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of centers to conduct multidisciplinary research on environmental factors that may be related to the development of women's health conditions. Requires each such center to: (1) conduct basic or clinical research; (2) develop protocols and conduct training programs for physicians, scientists, nurses, and other health and allied health professionals; (3) disseminate information to such professionals and the public; and (4) emphasize activities that are directed toward preventing the development in women of the diseases and conditions involved. Allows a center to use funds to provide stipends for health and allied health professionals enrolled in training programs.Requires each center to establish and maintain ongoing collaborations with community organizations in the geographic area served by the center, including organizations that represent women or children with disorders that appear to stem from environmental factors.Requires the Director to provide for the coordination of information among centers and ensure regular communication between them.

women environmental health disease prevention act amends public_health_service_act require director national_institute_of_environmental_health_sciences grants development operation centers conduct multidisciplinary research environmental factors related development women health conditions requires center conduct basic clinical research develop protocols conduct training programs physicians scientists nurses health allied health professionals disseminate information professionals public emphasize activities directed preventing development women diseases conditions involved allows center use funds provide stipends health allied health professionals enrolled training programs requires center establish maintain ongoing collaborations community organizations geographic area served center including organizations represent women children disorders appear stem environmental factors requires director provide coordination information centers ensure regular communication


Summary: Environmental Hormone Disruption Research Act of 2008 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to establish a comprehensive program to: (1) research the health effects on women and children that may result through disruption of the hormone systems; (2) carry out research, development, and demonstrations on technologies to mitigate the occurrence of hormone-disrupting pollutants in the environment and their unintended effects on ecological and wildlife health, in cooperation with the United States Geological Survey (USGS); and (3) coordinate U.S. research on hormone disruption with research conducted in other nations.Requires the program to provide for: (1) the collection and dissemination of scientifically valid information on human health effects of hormone-disrupting pollutants, the extent of human exposure to such pollutants, and the exposure of wildlife species to such pollutants and possible associated health effects; and (2) research on mechanisms by which such pollutants interact with biological systems, testing for hormone disruption, and the identity and fate of hormone-disrupting pollutants in the environment.Gives the Director principal responsibility for conducting and coordinating research on the unintended effects of hormone-disrupting pollutants on human health and the environment.Requires the Secretary of Health and Human Services to establish the Hormone Disruption Research Interagency Commission. Establishes a Hormone Disruption Research Panel to make recommendations on the design and implementation of the program.

environmental disruption research_act amends public_health_service_act require director national_institute_of_environmental_health_sciences establish comprehensive program research health effects women children result disruption systems carry research development demonstrations technologies mitigate occurrence disrupting pollutants environment unintended effects ecological wildlife health cooperation united_states_geological_survey usgs coordinate research disruption research conducted nations requires program provide collection dissemination scientifically valid information human health effects disrupting pollutants extent human exposure pollutants exposure wildlife species pollutants possible associated health effects research mechanisms pollutants interact biological systems testing disruption identity disrupting pollutants environment gives director principal responsibility conducting coordinating research unintended effects disrupting pollutants human health environment requires secretary health_and_human_services establish disruption research interagency commission establishes disruption research panel recommendations design implementation program


Summary: Eliminating Disparities in Breast Cancer Treatment Act of 2008 - Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to establish a breast cancer treatment quality performance system to: (1) assess and disclose publicly, through the use of quality measures, the quality of care provided for the treatment of breast cancer by specified health care providers; and (2) base payment to such providers for such treatment on their performance with respect to such measures. Requires reduced payments to providers that either do not submit data in accordance with the reporting process in the system, or furnish low quality care for treatment of breast cancer.

eliminating disparities breast cancer treatment act amends title xviii medicare social_security_act direct secretary health_and_human_services establish breast cancer treatment quality performance system assess disclose publicly use quality measures quality care provided treatment breast cancer specified health_care providers base payment providers treatment performance respect measures requires reduced payments providers submit data accordance reporting process system furnish low quality care treatment breast cancer


Summary: Human-Animal Hybrid Prohibition Act of 2008- Amends the federal criminal code to prohibit and to set penalties for: (1) creating or attempting to create a human-animal hybrid (a being with human and non-human tissue as specified in this Act); (2) transferring or attempting to transfer a human embryo into a non-human womb, or a non-human embryo into a human womb; or (3) transporting or receiving for any purpose a human-animal hybrid.

human animal hybrid prohibition act amends federal criminal code prohibit set penalties creating attempting create human animal hybrid human non human tissue specified act transferring attempting transfer human embryo non human non human embryo human transporting receiving purpose human animal hybrid


Summary: National Neurotechnology Initiative Act - Defines "neurotechnology" to mean the science and technology that allows an individual to analyze, understand, treat, and heal the brain and nervous system.Requires the Secretary of Health and Human Services to implement a National Neurotechnology Initiative, under which the Secretary shall: (1) establish goals, priorities, and metrics for evaluation for federal neurotechnology research, development, and commercialization; (2) increase the investment in federal research, development, and translational programs in neurotechnology to achieve such goals; and (3) increase interagency coordination.Requires the Secretary to establish the National Neurotechnology Coordination Office and the National Neurotechnology Advisory Council.Requires the Director of the National Institutes of Health (NIH) to develop the Blueprint for Neuroscience Research to: (1) identify pervasive challenges in neuroscience and any technological barriers to solving such challenges; and (2) support the development of new tools, training opportunities, and other resources to assist neuroscientists in basic and clinical research. Directs the Commissioner of Food and Drugs to require the Directors of the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health to improve the timelines of the review process for neurology and psychiatry.Requires the Director of the National Neurotechnology Coordination Office to establish the American Neurotechnology Study Center.

national initiative act defines mean science_and_technology allows individual analyze understand treat heal brain nervous system requires secretary health_and_human_services implement national initiative secretary shall establish goals priorities metrics evaluation federal research development commercialization increase investment federal research development translational programs achieve goals increase interagency coordination requires secretary establish national coordination office national advisory_council requires director national_institutes_of_health nih develop neuroscience research identify pervasive challenges neuroscience technological barriers solving challenges support development new tools training opportunities resources assist basic clinical research directs commissioner food_and_drugs require directors center_for_drug_evaluation_and_research center_for_biologics_evaluation_and_research center_for_devices_and_radiological_health improve timelines review process psychiatry requires director national coordination office establish american study center


Summary: National Trauma Institute Research Program Act - Directs the Secretary of Defense to establish a National Trauma Institute Research Program at the National Trauma Institute as a military-civilian public-private partnership to nationally fund trauma research.

national trauma institute research program act_-_directs secretary defense establish national trauma institute research program national trauma institute military civilian public private partnership nationally fund trauma research


Summary: Access to America's Orthopedic Services Act of 2008 - Requires the Secretary of Health and Human Services to establish criteria for accounting and reporting the effort expended by researchers on musculoskeletal research funded with certain grants.Sets forth reporting requirements related to musculoskeletal health, including on: (1) research funded by the National Institutes of Health (NIH); (2) federal programs and activities relating to musculoskeletal trauma care; (3) a standard unit for the measurement of bone mass under the Medicare program; (4) access to orthopedic services by certain federal health program beneficiaries; and (5) childhood musculoskeletal diseases, conditions, and injuries in the United States.Amends the Public Health Service Act to require the Organ Procurement and Transplantation Network to establish the Transplantation Transmission Sentinel Network to track disease transmission from organ, tissue, or eye transplants.Requires the Secretary to issue regulations relating to the accreditation of: (1) establishments engaged in the manufacture of human cells, tissues, and cellular and tissue-based products; and (2) personnel who participate in related activities.Requires the Secretary to conduct studies related to: (1) a national registry of artificial joint replacements in Medicare beneficiaries; (2) severe trauma to extremities resulting from motor vehicle crashes; (3) workplace-related musculoskeletal injuries and conditions; (4) funding available for graduate medical education in orthopedics; (5) methods for measuring bone mass in Medicare beneficiaries; and (6) aging in the United States.Requires the Secretary to: (1) conduct a national public awareness program on musculoskeletal health; and (2) award grants for certain health and aging activities for seniors.Provides for musculoskeletal diseases and conditions to be treated as a priority within the Office of Minority Health.

access america services act requires secretary health_and_human_services establish criteria accounting reporting effort expended researchers musculoskeletal research funded certain grants sets forth reporting requirements related musculoskeletal health including research funded national_institutes_of_health nih federal programs activities relating musculoskeletal trauma care standard unit measurement bone mass medicare program access services certain federal health program beneficiaries childhood musculoskeletal diseases conditions injuries united_states amends public_health_service_act require organ procurement transplantation network establish transplantation transmission network track disease transmission organ tissue eye requires secretary issue regulations relating accreditation establishments engaged manufacture human cells tissues cellular tissue based products personnel participate related activities requires secretary conduct studies related national_registry artificial joint replacements medicare beneficiaries severe trauma resulting motor vehicle crashes workplace related musculoskeletal injuries conditions funding available graduate medical education methods measuring bone mass medicare beneficiaries aging united_states requires secretary conduct national public awareness program musculoskeletal health award grants certain health aging activities seniors provides musculoskeletal diseases conditions treated priority office_of_minority_health


Summary: Genomics and Personalized Medicine Act of 2008 - Directs the Secretary of Health and Human Services to: (1) establish the Genomics and Personalized Medicine Interagency Working Group (IWG) to facilitate collaboration, coordination, and integration of activities among federal agencies relating to genomic research and initiatives; (2) expand and accelerate research and programs to collect genetic and genomic data that will advance the field of genomics and personalized medicine; (3) establish a national biobanking distributed database for the collection and integration of genomic data and associated environmental and clinical health information; (4) establish a grant program for academic medical centers and other entities to develop or expand biobanking initiatives; (5) improve genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders; (6) establish a registry on the analytical and clinical validity of laboratory-developed genetic tests; (7) contract with the National Academy of Sciences to study incentives to encourage companion diagnostic test development; and (8) make information available on the safety and efficacy of genetic tests and commission a study for improving federal oversight and regulation of such tests. Requires the Director of the Centers for Disease Control and Prevention (CDC) to: (1) conduct an analysis of the public health impact of direct-to-consumer marketing of genetic tests; and (2) expand efforts to educate the public about genomics and its health applications.Amends the Internal Revenue Code to establish a companion diagnostic tax credit for qualified diagnostic tests designed to provide information that can be used to increase the safety or effectiveness of a drug.

personalized medicine act directs secretary health_and_human_services establish personalized medicine interagency_working_group facilitate collaboration coordination integration activities federal agencies relating research initiatives expand accelerate research programs collect genetic data advance field personalized medicine establish national distributed database collection integration data associated environmental clinical health information establish grant program academic medical centers entities develop expand initiatives improve training diagnosis treatment counseling adults children rare common disorders establish registry analytical clinical validity laboratory developed genetic tests contract national_academy_of_sciences study incentives encourage companion diagnostic test development information available safety efficacy genetic tests commission study improving federal oversight regulation tests requires director centers_for_disease_control_and_prevention cdc conduct analysis public health impact direct consumer marketing genetic tests expand efforts educate public health applications amends_the_internal_revenue_code establish companion diagnostic tax credit qualified diagnostic tests designed provide information increase safety effectiveness drug


Summary: Pulmonary Fibrosis Research Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) develop a system to collect data on pulmonary fibrosis and other interstitial lung diseases; (2) establish the National PF Registry; and (3) establish the National Pulmonary Fibrosis Advisory Board.Allows the Secretary, acting through the Director of the CDC, to provide for the collection, analysis, and reporting of data on pulmonary fibrosis and other interstitial lung diseases that can be confused with, misdiagnosed as, and progress to pulmonary fibrosis.Requires the Secretary, in developing the Registry, to: (1) expand and coordinate existing data and surveillance systems, surveys, registries, and other federal public health and environmental infrastructure; and (2) provide for research access to pulmonary fibrosis data.Directs the Secretary to ensure that epidemiological and other types of information are made available to the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA).Requires the Director of the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate Institute pulmonary fibrosis research activities.Requires the Director of CDC to prepare the National Pulmonary Fibrosis Action Plan.Requires the Secretary to: (1) convene a summit of individuals with expertise in research and care of pulmonary fibrosis to provide a detailed overview of NIH research activities and discuss potential collaborations between NIH and other federal health agencies; and (2) make information about NIH activities relating to pulmonary fibrosis publicly available.

pulmonary fibrosis research enhancement act_-_amends public_health_service_act require secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc develop system collect data pulmonary fibrosis lung diseases establish national registry establish national pulmonary fibrosis advisory_board allows secretary acting director cdc provide collection analysis reporting data pulmonary fibrosis lung diseases progress pulmonary fibrosis requires secretary developing registry expand coordinate existing data surveillance systems surveys registries federal public health environmental infrastructure provide research access pulmonary fibrosis data directs secretary ensure epidemiological types information available national_institutes_of_health nih department_of_veterans_affairs director national_heart lung blood_institute expand intensify coordinate institute pulmonary fibrosis research activities requires director cdc prepare national pulmonary fibrosis action plan requires secretary convene summit individuals expertise research care pulmonary fibrosis provide detailed overview nih research activities discuss potential collaborations nih federal health agencies information nih activities relating pulmonary fibrosis publicly available


Summary: Tom Lantos Pulmonary Hypertension Research and Education Act of 2008 - Title I: Research on Pulmonary Hypertension - (Sec. 101) Expresses the sense of the Congress that: (1) the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Heart, Lung, and Blood Institute, should continue aggressive work on pulmonary hypertension; and (2) the Director of the Institute should continue research to expand the understanding of the causes of, and to find a cure for, pulmonary hypertension.Requires inclusion of information on the status of pulmonary hypertension research at NIH in biennial reports to Congress. Title II: Increasing Awareness of Pulmonary Hypertension - (Sec. 201) Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of pulmonary hypertension, which may include information on: (1) pulmonary hypertension and its symptoms; (2) the incidence and prevalence of pulmonary hypertension; (3) diseases and conditions that can lead to pulmonary hypertension as a secondary diagnosis; (4) the importance of early diagnosis; and (5) the availability of a range of treatment options.(Sec. 202) Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to carry out an educational campaign to increase awareness of pulmonary hypertension among health care providers, which may include information on: (1) the symptoms of pulmonary hypertension; (2) the importance of early diagnosis; (3) current diagnostic criteria; and (4) Food and Drug Administration-approved therapies for the disease. Requires such campaign to target health care providers, including cardiologists, pulmonologists, rheumatologists, primary care physicians, pediatricians, and nurse practitioners.Sets forth reporting requirements.Authorizes appropriations for FY2009-FY2011.

tom_lantos pulmonary hypertension research education act title research pulmonary hypertension sec expresses sense congress secretary health_and_human_services acting director national_institutes_of_health nih director national_heart lung blood_institute continue aggressive work pulmonary hypertension director institute continue research expand understanding causes find cure pulmonary hypertension requires inclusion information status pulmonary hypertension research nih biennial reports congress title increasing awareness pulmonary hypertension sec requires secretary acting director centers_for_disease_control_and_prevention cdc carry educational campaign increase public awareness pulmonary hypertension include information pulmonary hypertension symptoms incidence prevalence pulmonary hypertension diseases conditions lead pulmonary hypertension secondary diagnosis importance early diagnosis availability range treatment requires secretary acting administrator health_resources_and_services_administration hrsa director cdc carry educational campaign increase awareness pulmonary hypertension health_care providers include information symptoms pulmonary hypertension importance early diagnosis current diagnostic criteria food_and_drug_administration approved therapies disease requires campaign target health_care providers including primary care physicians pediatricians nurse practitioners sets forth reporting requirements authorizes appropriations fy2009 fy2011


Summary: Bone Marrow Failure Disease Research and Treatment Act of 2008 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) develop a system to collect data on acquired bone marrow failure diseases; (2) establish the National Acquired Bone Marrow Failure Disease Registry; and (3) establish the Advisory Committee on Acquired Bone Marrow Failure Diseases to provide recommendations to the Secretary on the Registry.Allows the Secretary, acting through the Director, to award grants to, and enter to contracts and cooperative agreements with, public or private nonprofit entities for the management of the Registry.Requires the Secretary, acting through the Administrator of the Agency for Toxic Substances and Disease Registry, to conduct pilot studies to determine which environmental factors may cause acquired bone marrow failure diseases.Requires the Secretary, acting through the Deputy Assistant Secretary for Minority Health, to: (1) establish outreach and information programs targeted to minority populations affected by such diseases; (2) undertake a coordinated outreach effort to connect Hispanic, Asian American, and Pacific Islander communities with comprehensive services focused on treatment of, and information about, such diseases; and (3) awards grants to, or enter into cooperative agreements with, entities to perform research on such diseases.Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to award grants to entities to improve diagnostic practices and quality of care with respect to patients with such diseases.

bone marrow failure disease research treatment act amends public_health_service_act require secretary health_and_human_services acting director centers_for_disease_control_and_prevention cdc develop system collect data acquired bone marrow failure diseases establish national acquired bone marrow failure disease registry establish advisory_committee acquired bone marrow failure diseases provide recommendations secretary registry allows secretary acting director award grants enter contracts cooperative agreements public private nonprofit entities management registry requires secretary acting administrator agency toxic substances disease registry conduct pilot studies determine environmental factors cause acquired bone marrow failure diseases requires secretary acting deputy assistant secretary minority health establish outreach information programs targeted minority populations affected diseases undertake coordinated outreach effort connect hispanic asian american pacific islander communities comprehensive services focused treatment information diseases awards grants enter cooperative agreements entities perform research diseases requires secretary acting director agency healthcare_research_and_quality ahrq award grants entities improve diagnostic practices quality care respect patients diseases


Summary: National Plan to Advance Pancreatic Cancer Act of 2008 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to establish and implement a Pancreatic Cancer Initiative to assist in coordinating activities to address the high mortality rate associated with pancreatic cancer.Requires the Secretary to establish the Interdisciplinary Pancreatic Cancer Coordinating Committee to: (1) provide advice on overall research objectives and benchmarks for pancreatic cancer research; (2) develop and annually update a strategic plan for pancreatic cancer research awareness; and (3) conduct evaluations and make recommendations to the Secretary, the Director of the National Institutes of Health (NIH), and the Director of the National Cancer Institute regarding the prioritization and award of NIH research grants relating to pancreatic cancer.Requires the Secretary to develop a primary care provider education program on pancreatic cancer.Requires the Director of NIH and the Director of the Centers for Disease Control and Prevention (CDC) to develop a communication tool kit for patients and their families that focuses on specific pancreatic cancer issues relating to patient choices and patient care.Allows the Secretary to award grants to research institutions for use in developing innovative compounds or technologies for the prevention, early detection, or treatment of those cancers with five-year survival rates of less than 50%. Requires the Secretary to focus on pancreatic cancer during the initial five fiscal years of awarding such grants.Allows the Secretary to designate two additional Specialized Programs of Research Excellence focusing solely on pancreatic cancer research.

national plan advance cancer act amends public_health_service_act require secretary health_and_human_services establish implement cancer initiative assist coordinating activities address high mortality rate associated cancer requires secretary establish interdisciplinary cancer coordinating committee provide advice overall research objectives benchmarks cancer research develop annually update strategic plan cancer research awareness conduct evaluations recommendations secretary director national_institutes_of_health nih director national_cancer_institute prioritization award nih research grants relating cancer requires secretary develop primary care provider education program cancer requires director nih director centers_for_disease_control_and_prevention cdc develop communication tool kit patients families focuses specific cancer issues relating patient choices patient care allows secretary award grants research institutions use developing innovative compounds technologies prevention early detection treatment cancers year survival rates requires secretary focus cancer initial fiscal years awarding grants allows secretary designate additional specialized programs research excellence focusing solely cancer research


Summary: Prevention, Awareness, and Research of Autoimmune Diseases Act of 2008 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institute of Environmental Health Sciences, to award grants for the conduct or support of research on environmental triggers that can cause the initiation of autoimmune diseases in genetically predisposed individuals. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to award grants to eligible entities to conduct public and professional awareness activities regarding autoimmune diseases. Allows grantees to use grant funds to: (1) promote increased awareness of early intervention and treatment to significantly improve the quality of life for people with autoimmune diseases; (2) target minority communities that may be underserved or disproportionately affected by such diseases; and (3) target women to help reduce the amount of time taken for correct diagnosis of such diseases. Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA), to: (1) award grants to eligible entities for the education of health care providers on potential links between autoimmune diseases and cognitive and mood disorders, such as depression; and (2) establish an educational loan repayment program for physicians agreeing to conduct research on autoimmune diseases.

prevention awareness research diseases act amends public_health_service_act require secretary health_and_human_services acting director national_institute_of_environmental_health_sciences award grants conduct support research environmental triggers cause initiation diseases genetically individuals requires secretary acting director centers_for_disease_control_and_prevention cdc award grants eligible entities conduct public professional awareness activities diseases allows grantees use grant funds promote increased awareness early intervention treatment significantly improve quality life people diseases target minority communities underserved disproportionately affected diseases target women help reduce time taken correct diagnosis diseases requires secretary acting administrator health_resources_and_services_administration hrsa award grants eligible entities education health_care providers potential links diseases cognitive disorders depression establish educational loan repayment program physicians agreeing conduct research diseases


Summary: Rachel's Act of 2008 - Directs the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to award a prize payment to the first person who develops a cure for clear cell sarcoma of the tendons and aponeuroses.

act directs secretary health_and_human_services acting director national_institutes_of_health nih award prize payment person develops cure clear cell


Summary: Protection for Participants in Research Act of 2008 - Amends the Public Health Service Act to require all human subject research conducted, supported, or otherwise subject to federal regulation, to be conducted in accordance with the Common Rule and the vulnerable-population rules, as set forth in the Code of Federal Regulations. Requires the Secretary of Health and Human Services to review and harmonize such regulations. Requires informed consent before an individual may be a subject of human research. Requires an Institutional Review Board to approve all human subject research proposals. Directs the Secretary to establish criteria for identifying and monitoring high-risk human subject research projects. Prohibits grants or awards to a public entity or private academic institution that does not have a program to educate investigators and Board members on the protection of human research subjects. Prohibits the use of federal funds for classified human subject research if: (1) the Board has waived the informed consent requirement; or (2) the research is exempt from Board review. Establishes the Office of Human Research Protections within the Office of the Secretary. Requires the Director of the Office to: (1) provide for the protection of human research subjects; (2) establish criteria regarding assurance of compliance with Common Rule requirements; and (3) coordinate federal activities with respect to the protection of human research subjects. Authorizes the Director to make grants for a model education program. Requires the Secretary to: (1) promulgate regulations enhancing the protection of people with diminished decisionmaking capacity participating in human subject research; and (2) study whether the number of certain members of Institutional Review Boards should be increased.

protection participants research_act amends public_health_service_act require human subject research conducted supported subject federal regulation conducted accordance common rule vulnerable population rules set forth code federal regulations requires secretary health_and_human_services review harmonize regulations requires informed consent individual subject human research requires institutional review board approve human subject research proposals directs secretary establish criteria identifying monitoring high risk human subject research projects prohibits grants awards public entity private academic institution program educate investigators board members protection human research subjects prohibits use federal funds classified human subject research board waived informed consent requirement research exempt board review establishes office human research protections office_of_the_secretary requires director office provide protection human research subjects establish criteria assurance compliance common rule requirements coordinate federal activities respect protection human research subjects authorizes director grants model education program requires secretary promulgate regulations enhancing protection people diminished decisionmaking capacity participating human subject research study number certain members institutional review boards increased


Summary: Stem Cell Research Enhancement Act of 2008 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment; (2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements.Requires the Director of the National Institutes of Health (NIH) to issue guidelines on research involving human embryonic stem cells. Authorizes the Director to issue guidelines on research involving other human stem cells, as scientifically warranted. Provides for updates of guidelines under this Act. Directs the Secretary to take into consideration guidelines on human stem cell research developed by nationally- and internationally- recognized scientific organizations.Requires NIH research to comply with guidelines under this Act.Requires the Director to: (1) determine the extent to which the guidelines under this Act apply to research on human embryonic stem cells derived before the effective date of such guidelines; and (2) include in its biennial report to Congress a summary of research activities on human stem cells.

stem cell research enhancement_act amends public_health_service_act require secretary health_and_human_services conduct support research utilizes human stem cells regardless date stem cells derived human embryo limits research stem cells meet following requirements stem cells derived human donated vitro fertilization clinics created purposes fertility treatment excess needs individuals seeking treatment prior donation determined implanted woman individuals seeking fertility treatment donated written informed consent received financial inducements requires director national_institutes_of_health nih issue guidelines research involving human stem cells authorizes director issue guidelines research involving human stem cells scientifically warranted provides updates guidelines act directs secretary consideration guidelines human stem cell research developed recognized scientific organizations requires nih research comply guidelines act requires director determine extent guidelines act apply research human stem cells derived effective date guidelines include biennial report congress summary research activities human stem cells


Summary: Directs the Secretary of the Interior, acting through the U.S. Geological Survey, to: (1) establish a National Biological Data Center to collect nonhuman biological data and make such data available for public use; and (2) contract with a small business to manage the Center. Sets forth duties of the Center, including the collection of nonhuman biological data from federal, public, private, and nonprofit entities and the development of partnerships with public and private entities, academic and scientific institutions to allow the Center to develop a digital network for the storage and retrieval of nonhuman biological data.

directs secretary interior acting geological survey establish national biological data center collect nonhuman biological data data available public use contract small business manage center sets forth duties center including collection nonhuman biological data federal public private nonprofit entities development partnerships public private entities academic scientific institutions allow center develop digital network storage retrieval nonhuman biological data


Summary: Stem Cell Research Enhancement Act of 2007 - (Sec. 2) Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would otherwise be discarded; and (3) such individuals donate the embryos with written informed consent and receive no financial or other inducements. Directs the Secretary to: (1) issue final guidelines to carry out this Act within 60 days; and (2) submit annual reports on activities and research conducted under this Act. (Sec. 3) Requires the Secretary to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research. Sets forth reporting requirements. Authorizes appropriations.

stem cell research enhancement_act sec amends public_health_service_act require secretary health_and_human_services conduct support research utilizes human stem cells regardless date stem cells derived human embryo limits research stem cells meet following ethical requirements stem cells derived human donated vitro fertilization clinics purpose fertility treatment excess needs individuals seeking treatment implanted woman individuals donate written informed consent receive financial inducements directs secretary issue final guidelines carry act days submit annual reports activities research conducted act sec requires secretary develop techniques isolation production testing stem cells capable producing cell types developing body result improved understanding treatments diseases adverse health conditions derived human embryo requires secretary provide guidance concerning steps required additional research prioritize research greatest potential near term clinical benefit account techniques outlined president council appropriate techniques research sets forth reporting requirements authorizes appropriations


Summary: Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act - (Sec. 3) Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or risk of injury to, a human embryo of embryos other than those that are naturally dead. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefits; (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research; and (4) require assurances from grant applicants, in the case of research involving stem cells from a naturally dead embryo, that no alteration of the timing, methods, or procedures used to create, maintain, or intervene in the development of a human embryo was made solely for the purpose of deriving the stem cells. Sets forth reporting requirements. Authorizes appropriations. (Sec. 4) Directs the Secretary to enter into a contract with the Institute of Medicine to conduct a study to: (1) recommend an optimal structure for an amniotic and placental stem cell bank program; and (2) address pertinent issues to maximize the potential of such technology.

hope offered ethical stem cell research_act hope act sec amends public_health_service_act require secretary health_and_human_services develop techniques isolation production testing stem cells including stem cells flexibility stem cells source result improved understanding treatments diseases adverse health conditions provided techniques involve creation human embryo research purposes destruction risk injury human embryo naturally dead requires secretary provide guidance concerning steps required additional research prioritize research greatest potential near term clinical benefits account techniques outlined president council appropriate techniques research require assurances grant applicants case research involving stem cells naturally dead embryo alteration timing methods procedures create maintain intervene development human embryo solely purpose deriving stem cells sets forth reporting requirements authorizes appropriations sec directs secretary enter contract institute_of_medicine conduct study recommend optimal structure stem cell bank program address pertinent issues maximize potential technology


Summary: Pluripotent Stem Cell Therapy Enhancement Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source) and that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a viable human embryo for research purposes; or (2) the destruction or discarding of a human embryo or embryos; or (3) knowingly subjecting a human embryo or embryos to risk of injury or death greater than that allowed for federal research on fetuses in utero under current law. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

stem cell therapy enhancement_act amends public_health_service_act require secretary health_and_human_services develop techniques isolation production testing stem cells flexibility stem cells source result improved understanding treatments diseases adverse health conditions provided techniques involve creation viable human embryo research purposes destruction human embryo knowingly subjecting human embryo risk injury death greater allowed federal research current law requires secretary provide guidance concerning steps required additional research prioritize research greatest potential near term clinical benefit account techniques outlined president council appropriate techniques research


Summary: National Center for Social Work Research Act - Amends the Public Health Service Act to establish the National Center for Social Work Research as an agency of the National Institutes of Health (NIH) to conduct, support, and disseminate targeted research on social work methods and outcomes related to problems of significant social concern. Authorizes the Director of the Center to: (1) provide research training and instruction; (2) establish research traineeships and fellowships; (3) provide stipends and allowances; and (4) make grants to nonprofit institutions to provide such training, instruction, traineeships, and fellowships. Directs the Secretary of Health and Human Services to establish an advisory council for the Center.

national center social work research act_-_amends public_health_service_act establish national center social work research agency national_institutes_of_health nih conduct support disseminate targeted research social work methods outcomes related problems significant social concern authorizes director center provide research training instruction establish research traineeships fellowships provide stipends allowances grants nonprofit institutions provide training instruction traineeships fellowships directs secretary health_and_human_services establish advisory_council_for_the_center


Summary: Establishes in the Uniformed Services University of the Health Sciences the United States Military Cancer Institute, headed by a Director, to carry out research studies on: (1) the epidemiological features of cancer among populations of various ethnic origins, as well as complementary research on oncologic nursing; (2) the prevention and early detection of cancer; and (3) basic, translational, and clinical investigation matters relating to such studies. Directs the Institute to conduct the study in collaboration with other cancer research organizations and entities selected by the Institute.

establishes uniformed_services university health sciences united_states military cancer institute headed director carry research studies epidemiological features cancer populations ethnic complementary research nursing prevention early detection cancer basic translational clinical investigation matters relating studies directs institute conduct study collaboration cancer research organizations entities selected institute


Summary: Stem Cell Research Expansion Act - Authorizes the Department of Health and Human Services to provide funding for research on embryonic stem cell lines that were created prior to January 23, 2006, that does not result in the use of federal funding to destroy an embryo.

stem cell research expansion act_-_authorizes department_of_health_and_human_services provide funding research stem cell lines created prior january result use federal funding destroy embryo


Summary: Hope Offered through Principled, Ethically-Sound Stem Cell Research Act or the HOPE Act - Requires the Secretary of Health and Human Services to conduct and support research to develop techniques for the isolation, derivation, production, or testing of pluripotent stem cells that have the flexibility of embryonic stem cells and that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a viable human embryo for research purposes; (2) the destruction or discarding of a human embryo; or (3) knowingly subjecting a human embryo to risk of injury or death greater than that allowed on fetuses in utero. Establishes the National Stem Cell Research Review Board to: (1) monitor research to ensure that it is in compliance with this Act; (2) prioritize research with the greatest potential for near term benefits; and (3) ensure fair consideration of both embryonic and adult stem cell research for funding. Sets forth consent requirements for the donation of materials for research. Applies federal provisions protecting individually identifiable health information to donors. Amends the National Organ Transplant Act to prohibit the transfer of any human ovum, human blastocyst, human embryo, or stem cell derived from a human embryo for valuable consideration. Amends the Public Health Service Act to prohibit any person from knowingly receiving any valuable consideration for any therapy that: (1) affects interstate commerce or is funded by federal assistance; and (2) utilizes cells from a human embryo if the process of deriving such cells destroyed the embryo.

hope offered sound stem cell research_act hope act_-_requires secretary health_and_human_services conduct support research develop techniques isolation production testing stem cells flexibility stem cells result improved understanding treatments diseases adverse health conditions provided techniques involve creation viable human embryo research purposes destruction human embryo knowingly subjecting human embryo risk injury death greater allowed establishes national stem cell research review board monitor research ensure compliance act prioritize research greatest potential near term benefits ensure fair consideration adult stem cell research funding sets forth consent requirements donation materials research applies federal provisions protecting individually identifiable health information donors amends national_organ_transplant_act prohibit transfer human human human embryo stem cell derived human embryo valuable consideration amends public_health_service_act prohibit person knowingly receiving valuable consideration therapy affects interstate commerce funded federal assistance utilizes cells human embryo process deriving cells destroyed embryo


Summary: Fair Access to Clinical Trials Act of 2007 or the FACT Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to establish and operate a data bank of information on clinical trials, to include: (1) a clinical trials registry of health-related interventions conducted to test the safety or effectiveness of any drug, biological product, or device intended to treat serious or life-threatening diseases and conditions; and (2) a clinical trial results database of health-related interventions to test the safety or effectiveness of any drug, biological product, or device. Requires the Commissioner of Food and Drugs to make available to the public: (1) the full reviews conducted by the Food and Drug Administration (FDA) of new or supplemental new drug applications, including documentation of significant differences of opinion and the resolution of those differences; and (2) copies of written consultations on a drug's safety conducted by the Office of Surveillance and Epidemiology. Requires the Secretary to assess civil monetary penalties for knowingly submitting inaccurate information to the FDA. Allows the Secretary to correct any information included in the registry or database that is factually and substantively inaccurate, false, or misleading. Extends requirements of this Act to clinical trials conducted outside of the United States under certain circumstances. Prohibits a responsible person or a manufacturer from performing any act that prohibits, limits, or imposes unreasonable delays on the ability of an individual to discuss or publish the results of a clinical trial. Requires the Secretary to enter into a contract with the Institute of Medicine to study the extent to which data submitted to the registry has impacted the public health.

fair access clinical trials act fact act_-_amends public_health_service_act require secretary health_and_human_services acting director national_institutes_of_health nih establish operate data bank information clinical trials include clinical trials registry health related interventions conducted test safety effectiveness drug biological product device intended treat life threatening diseases conditions clinical trial results database health related interventions test safety effectiveness drug biological product device requires commissioner food_and_drugs available public reviews conducted food_and_drug_administration fda new supplemental new drug applications including documentation significant differences opinion resolution differences copies written consultations drug safety conducted office surveillance epidemiology requires secretary assess civil monetary penalties knowingly submitting inaccurate information fda allows secretary correct information included registry database factually inaccurate false misleading extends requirements act clinical trials conducted outside united_states certain circumstances prohibits responsible person manufacturer performing act prohibits limits imposes unreasonable delays ability individual discuss publish results clinical trial requires secretary enter contract institute_of_medicine study extent data submitted registry impacted public health


Summary: Breast Cancer and Environmental Research Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH), to make grants to public or nonprofit private entities to conduct collaborative multidisciplinary and multi-institutional research on environmental factors that may be related to the etiology of breast cancer. Requires grantees to: (1) include community organizations representing a broad geographical area; (2) be a consortium of cooperating institutions and community groups; and (3) be supported under this Act for a period of not more than five years, with additional periods allowed after review and recommendation. Requires the Secretary to establish a Breast Cancer and Environmental Research Panel to: (1) develop a comprehensive research strategy for collaborative research; (2) make recommendations with respect to the mechanisms, peer review criteria, and allocations under this Act; (3) assist in the overall program evaluations; and (4) make recommendations for the dissemination of information on program process. Requires the Director of NIH to provide for coordination of information among, and an equitable geographical distribution of, grantees. Provides that nothing in this Act shall be construed to interfere with the technical and scientific peer review process at NIH. Authorizes appropriations for FY2008-FY2012.

breast cancer environmental research_act amends public_health_service_act require secretary health_and_human_services acting director national_institutes_of_health nih grants public nonprofit private entities conduct collaborative multidisciplinary multi institutional research environmental factors related breast cancer requires grantees include community organizations representing broad geographical area consortium cooperating institutions community groups supported act period years additional periods allowed review recommendation requires secretary establish breast cancer environmental research panel develop comprehensive research strategy collaborative research recommendations respect mechanisms peer_review criteria allocations act assist overall program evaluations recommendations dissemination information program process requires director nih provide coordination information equitable geographical distribution grantees provides act shall construed interfere technical scientific peer_review process nih authorizes appropriations fy2008 fy2012


Summary: Arthritis Prevention, Control, and Cure Act of 2007 - Amends the Public Health Service Act to require the Secretary of Health and Human Services: (1) to develop and implement a National Arthritis Action Plan; and (2) acting through the Director of the Centers for Disease Control and Prevention (CDC), to conduct, support, and promote the coordination of arthritis and other rheumatic diseases research. Requires the Secretary to award grants to: (1) support arthritis-specific research projects at the Centers for Prevention Research by the CDC; (2) support state comprehensive arthritis control and prevention programs and public health surveillance, prevention, and control activities; and (3) assist in the implementation of a national strategy for arthritis control and prevention. Requires the Secretary to coordinate a national education and outreach program on arthritis and other rheumatic diseases. Requires the Secretary to establish an Arthritis and Rheumatic Diseases Interagency Coordinating Committee to: (1) improve coordination of federal research activities related to arthritis and rheumatic diseases; and (2) convene a summit to provide a detailed overview of such current federal research. Requires the Director of the National Institutes of Health (NIH) to expand and intensify juvenile arthritis research. Allows the Secretary, acting through the Director of the CDC, to award grants to support juvenile arthritis data collection. Requires the Secretary, acting through the Director of the CDC, to support the development of a National Juvenile Arthritis Patient Registry. Requires the Secretary to promote and support pediatric rheumatology training, including by allowing the Secretary to establish a loan repayment program. Requires the Comptroller General to conduct a study on the economic impact of arthritis in the workplace.

prevention control cure act amends public_health_service_act require secretary health_and_human_services develop implement national action plan acting director centers_for_disease_control_and_prevention cdc conduct support promote coordination diseases research requires secretary award grants support specific research projects centers prevention research cdc support state comprehensive control prevention programs public health surveillance prevention control activities assist implementation national strategy control prevention requires secretary coordinate national education outreach program diseases requires secretary establish diseases interagency_coordinating_committee improve coordination federal research activities related diseases convene summit provide detailed overview current federal research requires director national_institutes_of_health nih expand intensify juvenile research allows secretary acting director cdc award grants support juvenile data collection requires secretary acting director cdc support development national juvenile patient registry requires secretary promote support pediatric training including allowing secretary establish loan repayment program requires comptroller_general conduct study economic impact workplace


Summary: Catastrophic Disaster Recovery Improvements Act of 2007 - Amends the Small Business Act to authorize the Administrator of the Small Business Administration (SBA), in providing SBA disaster relief assistance, to waive the prohibition on the duplication of benefits, including whether damage or destruction has been compensated for, credit is available from, or funds have been made available from any other source. Applies such amendment to any SBA assistance provided on or after August 29, 2005 (thereby ensuring applicability and retroactivity for victims of Hurricanes Katrina, Rita, and Wilma).

catastrophic disaster recovery improvements act amends small_business_act authorize administrator small_business_administration sba providing sba disaster relief assistance waive prohibition duplication benefits including damage destruction compensated credit available funds available source applies amendment sba assistance provided august ensuring applicability victims hurricanes katrina rita wilma